CVRx, Inc. (CVRX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Minneapolis, MN, United States. El CEO actual es Kevin Hykes.
CVRX tiene fecha de IPO 2021-06-30, 206 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $203.13M.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
